- Home
- SBFM
as 04-24-2025 4:00pm EST
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | FORT LAUDERDALE |
| Market Cap: | 4.9M | IPO Year: | N/A |
| Target Price: | $15.00 | AVG Volume (30 days): | 4.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.32 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.17 - $33.60 | Next Earning Date: | 05-19-2025 |
| Revenue: | $34,874,283 | Revenue Growth: | 44.75% |
| Revenue Growth (this year): | 192.48% | Revenue Growth (next year): | N/A |
Latest Sunshine Biopharma Inc. News
SBFM Breaking Stock News: Dive into SBFM Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
Sunshine Biopharma Unit Rolls Out Afinitor Alternative Everolimus in Canadian Market
ACCESS Newswire
4 days ago
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
MT Newswires
22 days ago
Sunshine Biopharma Closes $2.5 Million Direct Offering
ACCESS Newswire
22 days ago
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
ACCESS Newswire
23 days ago
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
MT Newswires
23 days ago
Sunshine Biopharma Completes Additional Studies of mRNA Therapy for Liver Cancer; Shares Up Pre-Bell
ACCESS Newswire
23 days ago
Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer
MT Newswires
23 days ago
Top Premarket Gainers
Compare SBFM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SBFM Sunshine Biopharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.